S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

GeneDx Names Quanterix CEO Everett Cunningham as Successor

Everett Cunningham will leave Quanterix for GeneDx, where he is set to take over as chief executive by Dec. 15. He will also join GeneDx’s board, succeeding Katherine Stueland, who has led the Gaithersburg, Md., company since 2021.

GeneDx Names Quanterix CEO Everett Cunningham as Successor

Stueland will remain in an advisory role through January 2027 to help with the transition, GeneDx said Wednesday. Cunningham joined Quanterix in January as its president, CEO and a board member, making his tenure there less than a year.

Quanterix said Jim Gute, its chief commercial officer since August, will serve as interim president and CEO while the company searches for a successor. It will consider both internal and external candidates. Quanterix shares recently fell 14% to $2.45 in premarket trading.

GeneDx said Cunningham’s compensation will include an initial annual base salary of $750,000, a $1.05 million sign-on bonus and an annual bonus targeted at 100% of his base pay.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!